1. Work package 4 report: benefit-risk tools and processes,2012
2. US Food and Drug Administration. Benefit-risk assessment in drug regulatory decision-making. Draft PDUFA VI implementation plan (FY 2018-2022), https://www.fda.gov/media/112570/download; 2018 [Accessed April 10, 2020]
3. Quantifying preferences in drug benefit-risk decisions;Tervonen;Clin Pharmacol Ther,2019
4. A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysis;Tervonen;Stat Med,2011
5. Applying multiple criteria decision analysis to comparative benefit-risk assessment: choosing among statins in primary prevention;Tervonen;Med Decis Making,2015